My Watchlist
Indicators
EL&P Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about ESALY

Recent news which mentions ESALY

< Previous 1 2 3 4 5 Next >
Why Biogen, Lilly, and Prothena Stocks Are Skyrocketing Today
Tickers BIIB ESALY LLY PRTA
Tags LLY Market News ESALY
From Motley Fool
Why Acumen Pharmaceuticals Stock Is Soaring Today
Tickers ABOS BIIB ESALY
Tags Trading Ideas ESALY Market News
From Benzinga
Why Is Cassava Sciences (SAVA) Stock Heating Up Today?
Tickers BIIB ESALY LLY SAVA
Tags BIIB LLY SAVA
From InvestorPlace
Why Is Biogen (BIIB) Stock Up 40% Today?
Tickers BIIB ESALY
Tags Market News ESALY BIIB
From InvestorPlace
Is iPhone Demand Really Slowing Down?, Lyft Freezes Hiring, Biogen's New Drug Slows Alzheimer's Progression: Top Financial Media Stories Wednesday, Sept. 28
Tickers AAPL AMZN BIIB BP
Tags General GM SHEL
From Benzinga
What In The World Is Going On With Biogen (BIIB) Shares?
Tickers BIIB ESALY
Tags Trading Ideas Benzinga Movers
From Benzinga
Why Cassava Sciences Shares Are Soaring Higher
Tickers BIIB ESALY SAVA
Tags Movers Benzinga SAVA
From Benzinga
Why Biogen Stock Is Up 40% Today
Tickers BIIB ESALY
Tags why it's moving Movers Benzinga
From Benzinga
2 Sympathy Plays To Watch For In The Wake Of Biogen's Positive Alzheimer's Drug Data
Tickers BIIB ESALY LLY RHHBY
Tags RHHBY Long Ideas News
From Benzinga
US Stock Futures Down Ahead Of Fed Speakers, Economic Data
Tickers AGCO BB BIIB CTAS
Tags News Pre/Market Outlook Market News
From Benzinga
Eisai shares indicated sharply higher after trial of experimental drug slows Alzheimer’s progression
Tickers BIIB ESALY
Tags BIIB ESALY JP:NIK
From MarketWatch
Alzheimer's Progression Slowed Down By Biogen's New Drug In Late-Stage Study: Analyst Sees 25% Upside For Stock
Tickers BIIB ESALY
Tags Analyst Ratings lecanemab Aduhelm
From Benzinga
Merck's Keytruda Combo Trial Fails To Meet Primary Goal In Liver Cancer
Tickers ESALF ESALY MRK
Tags ESALY Market News MRK
From Benzinga
Citi Is Bullish On This Large Pharma Stock On Upcoming Data Readout From Diabetes Candidate
Tickers ESALF ESALY LLY RHHBF
Tags Analyst Ratings Large Cap Benzinga
From Benzinga
Here's What Could Make This Beaten-Down Stock a Buy
Tickers BIIB ESALY
Tags Market News BIIB ESALY
From Motley Fool
Biotech Daily: Merck's Two Combo Cancer Trials Miss Main Goal, Approval For Sinovac's COVID-19 Shot For Youngest Kids, Alnylam Aces Protein Disorder Trial
Tickers ALNY AMRN ARQT BMRN
Tags Large Cap IBB FDA
From Benzinga
Merck's Two Keytruda Combo Cancer Trials Miss Primary Goal
Tickers ESALF ESALY MRK
Tags Benzinga Biotech Briefs
From Benzinga
Merck's Oncology Business Will Help It Crush the Bear Market
Tickers AZN ESALY MRK SGEN
Tags Market News ESALY MRK
From Motley Fool
Is This Biotech Stock a Bad News Buy?
Tickers BIIB ESALY
Tags BIIB Market News ESALY
From Motley Fool
The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer's Drug Due In January, FDA Reviews Roche's Lymphoma Candidate, Rare Pediatric Tag For Kazia's Pediatric Brain Cancer Candidate
Tickers AMTI BIIB ESALF ESALY
Tags BIIB SRPT Benzinga
From Benzinga
2 Safe Stocks to Buy in a Bear Market
Tickers AZN ESALY ISRG MDT
Tags AZN MRK ESALY
From Motley Fool
The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves
Tickers AGEN ARWR ATNX AVGR
Tags News ESALY General
From Benzinga
Eisai - Biogen Seek Accelerated Approval For Their Second Alzheimer's Drug
Tickers BIIB ESALF ESALY
Tags General Briefs Health Care
From Benzinga
1 Reason to Buy Biogen Now, and 1 Reason to Wait
Tickers BIIB ESALY SAGE
Tags Market News ESALY BIIB
From Motley Fool
Lilly’s experimental weight-loss drug may be a ‘multibillion-dollar opportunity’
Tickers ESALY LLY PFE SPX
Tags DK:NOVO/B PFE SPX
From MarketWatch
Is This Biotech Stock Worth the Trouble?
Tickers BIIB ESALY LLY SAGE
Tags Recent Press Releases SAGE Market News
From Motley Fool
What This Regulatory Approval Could Mean for Merck
Tickers ESALY MRK PFE
Tags ESALY Market News MRK
From Motley Fool
The Daily Biotech Pulse: SELLA In-licenses Oncology Asset, Merck's Pneumococcal Vaccine Review Extended, Arc Biopharma COVID Drug Flunks Mid-Stage Study
Tickers ABIO ESALY IBB IMMP
Tags Earnings ABIO TTOO
From Benzinga
Biogen, Eisai Unveil New Data On Another Alzheimer's Candidate, Lecanemab
Tickers BIIB ESALF ESALY
Tags ESALY Market News News
From Benzinga
FDA Approves Second Indication For Merck's Keytruda In Endometrial Cancer
Tickers ESALF ESALY MRK
Tags FDA Biotech Briefs
From Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.